Robinson Value Management
GSK icon

Robinson Value Management’s GSK GSK Stock Holding History

Robinson Value Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1
Closed -$52 – 80
2026
Q2 		$52 Sell
1
-53,989
-100% -$2.86M ﹤0.01% 75
2026
Q1 		$2.98M Sell
53,990
-2,178
-4% -$118K 1.66% 26
2025
Q4 		$2.75M Sell
56,168
-369
-0.7% -$17.2K 1.49% 27
2025
Q3 		$2.44M Sell
56,537
-232
-0.4% -$9.06K 1.42% 29
2025
Q2 		$2.18M Sell
56,769
-272
-0.5% -$10.4K 1.37% 30
2025
Q1 		$2.21M Sell
57,041
-60
-0.1% -$2.2K 1.43% 32
2024
Q4 		$1.93M Buy
57,101
+1,494
+3% +$53.8K 1.28% 35
2024
Q3 		$2.27M Sell
55,607
-60,849
-52% -$2.49M 1.48% 30
2024
Q2 		$4.48M Sell
116,456
-2,414
-2% -$102K 3.12% 7
2024
Q1 		$5.1M Sell
118,870
-9,209
-7% -$380K 3.42% 6
2023
Q4 		$4.75M Sell
128,079
-37
-0% -$1.33K 3.12% 7
2023
Q3 		$4.64M Sell
128,116
-3,561
-3% -$126K 3.46% 5
2023
Q2 		$4.69M Buy
131,677
+2,738
+2% +$98.2K 3.4% 4
2023
Q1 		$4.59M Sell
128,939
-3,179
-2% -$111K 3.52% 4
2022
Q4 		$4.64M Buy
132,118
+1,142
+0.9% +$38K 4% 3
2022
Q3 		$3.86M Buy
130,976
+54,838
+72% +$2.08M 3.84% 4
2022
Q2 		$4.14M Sell
76,138
-539
-0.7% -$29.8K 3.84% 5
2022
Q1 		$4.18M Sell
76,677
-1,465
-2% -$79.6K 3.24% 7
2021
Q4 		$4.31M Buy
78,142
+550
+0.7% +$28.6K 3.54% 7
2021
Q3 		$3.71M Buy
77,592
+39,877
+106% +$2M 3.31% 7
2021
Q2 		$1.88M Sell
37,715
-125
-0.3% -$6.01K 1.53% 29
2021
Q1 		$1.69M Sell
37,840
-1,880
-5% -$85.3K 1.39% 31
2020
Q4 		$1.83M Buy
+39,720
New +$1.82M 1.74% 28

Other funds holding GSK

Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Sound Income Strategies
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return
Keystone Financial Planning
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
Bell Bank
Bell Bank Fargo, North Dakota $2.66B AUM 18.07% 1-Year Est. Return

Robinson Value Management's GSK Position: Q3 2026 in Review

Robinson Value Management sold out of GSK (GSK) in Q3 2026, closing a stake of 1 share — an estimated $52 sold.

Robinson Value Management first reported a position in GSK in Q4 2020 and held it in 23 quarters. The position peaked at $5.1M in Q1 2024. 266 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Robinson Value Management reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
  • Robinson Value Management sold 1 GSK share in Q3 2026, an estimated $52.
  • Robinson Value Management first reported a position in GSK in Q4 2020 and held it in 23 quarters.
  • Robinson Value Management's GSK position peaked at $5.1M in Q1 2024.
  • 266 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Robinson Value Management's 13F filing for Q3 2026, filed 20 Oct 2026.